Blueberries Medical Corp.
BBRRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 63.5% | 22.4% | 69.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 34.9% | 29.2% | -7.5% | -176.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $2 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -193.7% | -477.4% | -570.9% | -692.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$4 |
| Pre-Tax Income | -$1 | -$2 | -$1 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$1 | -$5 |
| % Margin | -243.6% | -567.3% | -623.4% | -3,709.6% |
| EPS | -0.003 | -0.008 | -0.009 | -0.035 |
| % Growth | 61.3% | 13.8% | 74.9% | – |
| EPS Diluted | -0.003 | -0.008 | -0.009 | -0.035 |
| Weighted Avg Shares Out | 399 | 219 | 169 | 149 |
| Weighted Avg Shares Out Dil | 399 | 219 | 169 | 149 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -221.3% | -423.8% | -572.9% | -781.9% |